ACHN:
Analysis & Opinions
-
November 12, 2012
Currently, the Nasdaq has declined 0.1%, the S&P 500 is unchanged and the Dow has slipped 0.1%. The recent surge in ...
-
November 12, 2012
The Nasdaq has decreased 0.1%, the S&P 500 has moved little and the Dow is trading down 0.1% so far today. The ...
-
October 12, 2012
On a bad day for the market, the Nasdaq has declined 0.2%, the S&P 500 has slipped 0.4% and the Dow has fallen 0.2%. ...
-
September 19, 2012
On a good day for the market, the Nasdaq has increased 0.1%, the S&P 500 is trading up 0.2% and the Dow is up 0.3%. ...
-
January 09, 2012
Bristol-Myers recently bought Inhibitex, a company leading the way in developing a treatment for Hepatitis C.
-
November 22, 2011
Gilead is going all in on Hep C, as it acquires Pharmasset in a massive deal.
-
June 02, 2011
Check out May's Best Performing Healthcare Stocks!
-
September 10, 2010
Bristol-Myers is paying a lot, but a successful HCV franchise could be worth much more.
-
May 10, 2010
Should investors hang on despite a devastating FDA decision?
